跳至主要内容
临床试验/IRCT20240216061023N1
IRCT20240216061023N1招募中3 期

Comparing the efficacy of Toxin Botulinum type A with commercial names, MASPORT and DYSPORT in Benign Essential Blepharospasm: a Double blind Randomized Clinical Trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Clinically diagnosed with BEB
  • Without prior BTX-A injection in the previous 6 month
  • History of previous eyelid surgery

排除标准

  • pregnancy or lactation
  • secondary causes of Blepharospasm
  • History of disorders of the neuromuscular junction like myasthenia gravis, Eaton-Lambert Syndrome, and psychological instability
  • prescription of antispastic, muscle relaxants or medications affecting neuromuscular junction transmission such as aminoglycosides

研究者

相似试验